Oramed Stock Drops ~70% as Diabetes Drug Fails in Phase 3 Study
juststock/iStock via Getty Images Oramed Pharmaceutical' (NASDAQ:ORMP) the drug ORMD-0801 failed to meet the primary endpoint of improving blood sugar ...
juststock/iStock via Getty Images Oramed Pharmaceutical' (NASDAQ:ORMP) the drug ORMD-0801 failed to meet the primary endpoint of improving blood sugar ...